Akari Therapeutics (AKTX) EBITDA (2014 - 2025)
Akari Therapeutics (AKTX) EBITDA from Mar 31, 2014 to Sep 30, 2025. The TTM Akari Therapeutics (AKTX) EBITDA is -$18M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Akari Therapeutics (AKTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +161.13% |
| 3 Years | +24.39% |
| 5 Years | +13.99% |
| 10 Years | -16.65% |
| All Time | +12.64% |
Annual EBITDA change of Akari Therapeutics (AKTX)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$13M | -40.45% |
| 2024 | -$22M | +28.75% |
| 2023 | -$17M | -27.21% |
| 2022 | -$23M | +34.11% |
| 2021 | -$17M | -4.23% |
| 2020 | -$18M | +6.08% |
| 2019 | -$17M | -18.36% |
| 2018 | -$21M | -45.02% |
| 2017 | -$38M | +38.70% |
| 2016 | -$27M | -10.99% |
| 2015 | -$31M | +200.59% |
| 2014 | -$10M | +182.50% |
| 2013 | -$3.60M | -1.64% |
| 2012 | -$3.66M | +62.67% |
| 2011 | -$2.25M | +184.81% |
| 2010 | -$790K | -21.78% |
| 2009 | -$1.01M | -29.37% |
| 2008 | -$1.43M | -54.31% |
| 2007 | -$3.13M | +76.84% |
| 2006 | -$1.77M | N/A |